Your Complete Guide to Global Clinical Research and GCP Compliance
Safety Definitions & Causality Assessment in Practice: Step-by-Step Guide for Sponsors and CROs The landscape of clinical trials is complex, especially when it comes to ensuring the safety of trial participants. With the increasing emphasis on patient safety and data integrity, it is essential for clinical operations, regulatory affairs, and medical affairs professionals to fully…
Common Pitfalls in Safety Definitions & Causality Assessment—and How to Avoid Regulatory Findings Common Pitfalls in Safety Definitions & Causality Assessment—and How to Avoid Regulatory Findings Introduction to Safety Definitions in Clinical Trials In the context of clinical trials, the precise definition of safety is fundamental. Safety definitions guide investigators and sponsors in identifying and…
Safety Definitions & Causality Assessment: End-to-End Compliance Framework for Global Clinical Trials Safety Definitions & Causality Assessment: End-to-End Compliance Framework for Global Clinical Trials The conduct of clinical trials is a complex endeavor that necessitates adherence to various regulatory frameworks and guidelines. A crucial aspect of clinical trials is the management of safety-related data, including…
How to Design Safety Definitions & Causality Assessment That Meets FDA, EMA and MHRA Expectations How to Design Safety Definitions & Causality Assessment That Meets FDA, EMA and MHRA Expectations In the context of clinical trials, particularly for the nash clinical research network, establishing robust safety definitions and conducting appropriate causality assessments are critical elements…
Safety Monitoring in Observational Studies: A Regulator-Ready Playbook (2025) Safety Monitoring in Observational Studies That Withstands Regulatory Scrutiny Purpose, Principles, and the Global Compliance Frame for Observational Safety Observational studies—registries, cohorts, case-control studies, claims/EHR analytics, and pragmatic programs—are powerful engines for characterizing real-world safety. But the same qualities that make real-world data (RWD) valuable—scale, heterogeneity,…
Read More “Safety Monitoring in Observational Studies: A Regulator-Ready Playbook (2025)” »
Adverse Event Reporting and SAE Management — Ensuring Safety, Compliance, and Regulatory Accountability Effective Accountability in Adverse Event Reporting and SAE Management for Enhanced Compliance Adverse event (AE) management forms the ethical and regulatory backbone of clinical research. Every data point captured in a clinical trial represents a human experience — and any deviation in…
Pharmacovigilance and Drug Safety — Ensuring Continuous Protection Across the Product Lifecycle Pharmacovigilance and Drug Safety: Guaranteeing Continuous Protection Throughout the Product Pharmacovigilance (PV) is the science and practice of detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems. It ensures that patient safety remains central throughout a product’s lifecycle — from…
Clinical Trial Lifecycle: A Compliance-Ready Blueprint from Concept to Close-Out Running a Trial End-to-End: Practical Steps for a Clean, Defensible Lifecycle Concept & Feasibility: Turning an Idea into a Regulatable Plan The clinical trial lifecycle begins long before a protocol number exists. At concept, sponsors translate a medical hypothesis into a testable question that can…
Read More “Clinical Trial Lifecycle: A Compliance-Ready Blueprint from Concept to Close-Out” »
Phases I–IV and Post-Marketing Studies: Global, Compliance-Ready Playbook for Sponsors and Sites Mastering Clinical Trial Phases and Post-Marketing Evidence: A Practical Compliance Blueprint Regulatory Scope, Scientific Purpose, and Phase Intent Clinical development progresses through a structured sequence—first-in-human learning, proof-of-concept, confirmatory efficacy, and real-world safety/effectiveness reinforcement—so that each phase answers specific questions under Good Clinical Practice…